Get the Stockscreener App
3.96
0.63%
-0.025
Precision Biosciences Inc stock is traded at $3.96, with a volume of 225.08K.
It is down -0.63% in the last 24 hours and down -10.41% over the past month.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.
See More
Previous Close:
$3.985
Open:
$3.98
24h Volume:
225.08K
Relative Volume:
1.02
Market Cap:
$95.32M
Revenue:
$52.29M
Net Income/Loss:
$-73.52M
P/E Ratio:
-6.00
EPS:
-0.66
Net Cash Flow:
$-100.45M
1W Performance:
-5.71%
1M Performance:
-10.41%
6M Performance:
-17.50%
1Y Performance:
-23.99%
1-Day Range:
$3.83
$4.02
1-Week Range:
$3.83
$4.20
52-Week Range:
$3.7484
$8.82
Precision Biosciences Inc Stock (DTIL) Company Profile
Name
Precision Biosciences Inc
Sector
Industry
Phone
919-314-5512
Address
302 EAST PETTIGREW STREET, DURHAM, NC
Compare DTIL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DTIL
Precision Biosciences Inc
|
3.96 | 95.93M | 52.29M | -73.52M | -100.45M | -0.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.90 | 120.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.45 | 78.77B | 14.34B | 4.50B | 3.88B | 41.57 |
|
ARGX
Argen X Se Adr
|
840.50 | 52.46B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
338.06 | 45.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
340.38 | 38.73B | 4.98B | 69.59M | 525.67M | 0.5197 |
Precision Biosciences Inc Stock (DTIL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-25 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Apr-30-24 | Initiated | Guggenheim | Buy |
| Jun-17-22 | Initiated | BMO Capital Markets | Outperform |
| Jun-09-22 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-27-20 | Resumed | BTIG Research | Buy |
| Apr-03-20 | Downgrade | Goldman | Buy → Neutral |
| Mar-05-20 | Initiated | Stifel | Buy |
| Feb-25-20 | Initiated | William Blair | Outperform |
| Aug-09-19 | Initiated | BTIG Research | Buy |
| Jul-16-19 | Initiated | H.C. Wainwright | Buy |
| Apr-22-19 | Initiated | Barclays | Overweight |
| Apr-22-19 | Initiated | Goldman | Buy |
| Apr-22-19 | Initiated | JP Morgan | Overweight |
| Apr-22-19 | Initiated | Jefferies | Buy |
View All
Precision Biosciences Inc Stock (DTIL) Latest News
Aberdeen Group plc Acquires Significant Stake in Precision BioSc - GuruFocus
Aug Decliners: Can WRLD weather a recessionMarket Volume Summary & Weekly Watchlist of Top Performers - baoquankhu1.vn
Signal Recap: Is Precision BioSciences Inc likely to announce a buybackWeekly Trading Summary & Intraday High Probability Alerts - baoquankhu1.vn
Chart Watch: Should I average down on KDLY stock2025 Market Overview & Fast Entry High Yield Stock Tips - baoquankhu1.vn
Precision BioSciences launches $75M stock and warrant offering - MSN
Aug Mood: What is DURECT Corporations book value per shareWatch List & Low Drawdown Momentum Ideas - baoquankhu1.vn
Michael Amoroso Sells 34,799 Shares of Precision BioSciences (NASDAQ:DTIL) Stock - MarketBeat
Precision BioSciences (NASDAQ:DTIL) Insider J. Jefferson Smith Sells 10,200 Shares - MarketBeat
Precision BioSciences (NASDAQ:DTIL) CFO Sells $61,308.39 in Stock - MarketBeat
Precision Biosciences CFO sells $61k in shares By Investing.com - Investing.com UK
Precision Biosciences chief research officer Smith sells $41k in shares By Investing.com - Investing.com Nigeria
Scimeca, Precision Bio general counsel, sells $35,681 in DTIL stock By Investing.com - Investing.com Canada
Precision Biosciences chief research officer Smith sells $41k in shares - Investing.com
Genome Editing Market Forecast to Reach $23.6 Billion by 2031 Registering 16.6% CAGR: Insights Into Technology and Investment Trends - GlobeNewswire Inc.
Precision BioSciences (NASDAQ:DTIL) Trading Down 3.8%Time to Sell? - MarketBeat
Guidance Update: Is Precision BioSciences Inc stock trending bullishIPO Watch & Pattern Based Trade Signal System - baoquankhu1.vn
Aug Levels: How does Precision BioSciences Inc perform in inflationary periods2025 Dividend Review & Fast Gain Swing Alerts - baoquankhu1.vn
Trend Recap: Will Precision BioSciences Inc stock benefit from green energy trends2025 Price Action Summary & Technical Pattern Based Signals - Bộ Nội Vụ
Precision BioSciences Highlights 2026 Gene Editing Priorities - TipRanks
Precision BioSciences advances gene editing programs with key milestones By Investing.com - Investing.com Nigeria
Aug Catalysts: Is Precision BioSciences Inc stock trending bullishPortfolio Value Summary & Detailed Earnings Play Strategies - baoquankhu1.vn
Precision BioSciences advances gene editing programs with key milestones - Investing.com
Precision BioSciences Sets Strategic Priorities for 2026 Focused on Continued Advancement of Clinical-Stage Programs PBGENE-HBV for Chronic Hepatitis B and PBGENE-DMD for Duchenne Muscular Dystrophy - Business Wire
Precede Biosciences Secures $83.5M in Total Financing to Scale Next-Generation Precision Diagnostics Platform - GlobeNewswire
Precision BioSciences Shares Surge Following FDA Rare Pediatric Disease Designation - MSN
Will Precision BioSciences Inc. stock outperform Nasdaq indexMarket Performance Recap & Detailed Earnings Play Alerts - ulpravda.ru
Can Precision BioSciences Inc. (PBS0) stock deliver strong annual returns2025 Short Interest & Accurate Buy Signal Alerts - Улправда
Can Precision BioSciences Inc. stock reach $100 price targetJuly 2025 Price Swings & Verified Swing Trading Watchlists - Улправда
Is Precision BioSciences Inc. stock a top pick in earnings seasonEarnings Performance Report & AI Driven Price Forecasts - Улправда
Will Precision BioSciences Inc. stock split again soon2025 Winners & Losers & Low Drawdown Investment Strategies - Улправда
How Precision BioSciences Inc. stock compares to market leadersWeekly Market Outlook & Smart Swing Trading Techniques - Улправда
Can Precision BioSciences Inc. stock hit analyst price targetsQuarterly Trade Review & Low Drawdown Investment Ideas - Улправда
Is Precision BioSciences Inc. (PBS0) stock a top hedge fund pickIPO Market Watch & Free High Yield Investment Strategies - Улправда
Precision BioSciences: Tiny Gene-Editing Stock Caught Between Deep Cuts and Big Optionality - AD HOC NEWS
Precision Bio's DMD Therapy Gets Rare Pediatric Status, But Stock Slides; Retail Crowd Sees ‘Good Risk-Reward’ - MSN
What drives Precision BioSciences Inc PBS0 stock priceSell Signals and Alerts & Low Cost Portfolio Tips - earlytimes.in
Sterling Tools Limited Ranks High in Smart Money TrackerFundamental Strength Indicators & Explosive Profit Growth - earlytimes.in
Aug Ideas: Is Precision BioSciences Inc stock a top pick in earnings season - moha.gov.vn
Short Interest in Precision BioSciences, Inc. (NASDAQ:DTIL) Expands By 27.4% - MarketBeat
Earnings Update: Is Precision BioSciences Inc stock a top pick in earnings seasonWeekly Earnings Recap & Consistent Profit Trading Strategies - Bộ Nội Vụ
Precision Biosciences Inc files for mixed shelf of up to $250 millionSEC filing - MarketScreener
Precision BioSciences: Potential Proof-Of-Concept Data For HBV Cure In 2026 (NASDAQ:DTIL) - Seeking Alpha
Will Precision BioSciences Inc. stock benefit from infrastructure spendingMarket Breadth Indicators & Investor Community Interactions - bollywoodhelpline.com
Can Precision BioSciences Inc. stock maintain operating marginsEarnings Volatility Patterns & Affordable Stock Picks - bollywoodhelpline.com
Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - 01net
What analysts say about Precision BioSciences Inc PBS0 stockInstitutional Buying Trends & Free Explosive Trading Growth - earlytimes.in
Precision BioSciences Earnings Notes - Trefis
Will Precision BioSciences Inc. stock gain from government policies2025 Price Targets & Free Safe Capital Growth Stock Tips - Улправда
How Precision BioSciences Inc. stock compares to industry benchmarksWeekly Investment Summary & Weekly Watchlist for Consistent Profits - Улправда
How Precision BioSciences Inc. stock reacts to global recession fearsNew Guidance & Technical Pattern Based Buy Signals - DonanımHaber
Market Recap: How Precision BioSciences Inc. stock reacts to global recession fears2025 Price Targets & Scalable Portfolio Growth Methods - DonanımHaber
Precision Biosciences Inc Stock (DTIL) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):